DK236288A - Middel til fremme af dyrevaekst - Google Patents

Middel til fremme af dyrevaekst

Info

Publication number
DK236288A
DK236288A DK236288A DK236288A DK236288A DK 236288 A DK236288 A DK 236288A DK 236288 A DK236288 A DK 236288A DK 236288 A DK236288 A DK 236288A DK 236288 A DK236288 A DK 236288A
Authority
DK
Denmark
Prior art keywords
growth
animals
digesting enzymes
promoting agent
enzymes
Prior art date
Application number
DK236288A
Other languages
English (en)
Other versions
DK171626B1 (da
DK236288D0 (da
Inventor
Thomas Ko Sai Ying
Original Assignee
Thomas Ko Sai Ying
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3771790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK236288(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thomas Ko Sai Ying filed Critical Thomas Ko Sai Ying
Publication of DK236288A publication Critical patent/DK236288A/da
Publication of DK236288D0 publication Critical patent/DK236288D0/da
Application granted granted Critical
Publication of DK171626B1 publication Critical patent/DK171626B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Enzymes And Modification Thereof (AREA)
DK236288A 1986-08-28 1988-04-28 Vækstfremmende middel til dyr samt fremgangsmåde til fremstilling af og anvendelse af midlet til fremme af dyrevækst DK171626B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPH771486 1986-08-28
AUPH771486 1986-08-28
PCT/AU1987/000269 WO1988001512A1 (en) 1986-08-28 1987-08-17 Animal growth promotant
AU8700269 1987-08-17

Publications (3)

Publication Number Publication Date
DK236288A true DK236288A (da) 1988-04-28
DK236288D0 DK236288D0 (da) 1988-04-28
DK171626B1 DK171626B1 (da) 1997-03-03

Family

ID=3771790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK236288A DK171626B1 (da) 1986-08-28 1988-04-28 Vækstfremmende middel til dyr samt fremgangsmåde til fremstilling af og anvendelse af midlet til fremme af dyrevækst

Country Status (13)

Country Link
US (2) US5567423A (da)
EP (1) EP0319545B1 (da)
JP (1) JP2593501B2 (da)
KR (1) KR940000065B1 (da)
CN (1) CN87105846A (da)
AU (1) AU604052B2 (da)
CA (1) CA1322159C (da)
DE (1) DE3777658D1 (da)
DK (1) DK171626B1 (da)
ES (1) ES2004989A6 (da)
MY (1) MY101342A (da)
NZ (1) NZ221577A (da)
WO (1) WO1988001512A1 (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU604052B2 (en) * 1986-08-28 1990-12-06 Enzacor Properties Limited Animal growth promotant
JP2798248B2 (ja) * 1986-08-28 1998-09-17 コーテックス リミテッド 生物学的活性物質の動物の腸管部位へのデリバリーに有効なマイクロ顆粒状製剤
ES2042292T3 (es) * 1989-03-17 1993-12-01 Pitman-Moore, Inc. Dispositivo de administracion de proteinas macromoleculares por liberacion controlada.
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
JPH06508371A (ja) 1991-06-21 1994-09-22 ユニバーシティー オブ シンシナティ 経口投与できる治療用タンパク質及びその製法
JPH0785700B2 (ja) * 1992-03-10 1995-09-20 全国農業協同組合連合会 鶏用酸素固定化グリットおよび鶏用飼料の消化率向上方法
CA2137674A1 (en) * 1992-06-30 1994-01-06 Tracey L. Mynott Use of enzymes, especially bromelain, in the treatment of diarrhoea
DE19531173A1 (de) * 1995-08-24 1997-02-27 Boehringer Mannheim Gmbh Verfahren zum Stabilisieren des Gehalts glykierten Proteins einer Probe auf einem Matrixmaterial
WO1998009645A1 (en) * 1996-09-04 1998-03-12 Dott Research Laboratory Peptide-containing drug compositions for oral administration
TW409035B (en) 1997-06-04 2000-10-21 Gist Brocades Bv Starch-based enzyme granulates
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
US6559158B1 (en) 1997-11-03 2003-05-06 Ur Labs, Inc. Use of methylnaltrexone and related compounds to treat chronic opioid use side affects
US6274591B1 (en) * 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds
CA2322641C (en) 1998-03-23 2010-02-16 General Mills, Inc. Encapsulation of components into edible products
KR20010042579A (ko) 1999-02-10 2001-05-25 윌리암 로엘프 드 보에르 사료-효소 함유 과립
DE19929257A1 (de) 1999-06-25 2000-12-28 Basf Ag Polymerbeschichtete, granulierte enzymhaltige Futtermittelzusätze und Verfahren zu deren Herstellung
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
AUPR272901A0 (en) 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
US20030022909A1 (en) * 2001-06-05 2003-01-30 University Of Chicago Use of methylnaltrexone to treat immune suppression
ES2187378B2 (es) * 2001-11-14 2004-06-01 Alberto Vaquero Hernandez Formulacion de un pienso para el control del perfil de acidos grasos de la carne de cerdo.
CN100345494C (zh) 2002-01-15 2007-10-31 巴斯福股份公司 含饲料酶的颗粒
BRPI0409128A (pt) * 2003-04-08 2006-03-28 Progenics Pharm Inc uso de antagonistas de opióides periféricos, especialmente metilnaltrexona para tratar sìndrome de intestino irritável
CA2521420A1 (en) * 2003-04-08 2004-10-28 Progenics Pharmaceuticals, Inc. Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist
ES2528669T3 (es) * 2003-04-08 2015-02-11 Progenics Pharmaceuticals, Inc. Formulaciones farmacéuticas que contienen metilnaltrexona
US20040266727A1 (en) * 2003-06-25 2004-12-30 Brandon Steve F. Nutritional supplement having a unique soluble and insoluble fiber blend and method of making the same
BRPI0606587A2 (pt) * 2005-01-20 2009-07-07 Progenics Pharmaceuticais Inc uso de metilnaltrexona e compostos correlatos para tratar disfunção gastrintestinal pós-operatória
WO2006096626A2 (en) 2005-03-07 2006-09-14 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
US20080194611A1 (en) * 2005-06-03 2008-08-14 Alverdy John C Modulation of Cell Barrier Dysfunction
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
US20070197895A1 (en) * 2006-02-17 2007-08-23 Sdgi Holdings, Inc. Surgical instrument to assess tissue characteristics
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
PE20090700A1 (es) 2007-03-29 2009-07-13 Progenics Pharm Inc Compuestos heterociclicos como antagonistas del receptor opioide periferico
PL2139890T3 (pl) 2007-03-29 2014-11-28 Wyeth Llc Antagoniści obwodowych receptorów opioidowych i ich zastosowania
BRPI0809579B8 (pt) 2007-03-29 2021-05-25 Progenics Pharm Inc formas cristalinas e seus usos
WO2009099411A1 (en) 2008-02-06 2009-08-13 Progenics Pharmaceuticals, Inc. Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
AU2009225434B2 (en) 2008-03-21 2014-05-22 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
AU2009265034B2 (en) 2008-07-01 2015-09-03 University Of Chicago Particles containing an opioid receptor antagonist and methods of use
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
CN103118547A (zh) * 2010-01-15 2013-05-22 凯敏工业公司 受保护的α-淀粉酶
GB201311272D0 (en) 2013-06-25 2013-08-14 Ucl Business Plc Anti-microbial agents and uses thereof
JP2016526907A (ja) * 2013-07-30 2016-09-08 ベネミルク オーワイＢｅｎｅｍｉｌｋ Ｏｙ 泌乳反芻動物用飼料
CN103461225B (zh) * 2013-07-30 2015-12-23 仙桃市强农水产专业合作社 黄鳝网箱人工仿生态苗种繁育方法
EP3206491B1 (en) 2014-10-17 2019-11-27 Salix Pharmaceuticals, Inc. Use of methylnaltrexone to attenuate tumor progression
WO2017189322A1 (en) 2016-04-25 2017-11-02 Cargill, Incorporated Dissolvable micro-ingredient containers and methods for preparing animal feeds using such containers
CN112425538B (zh) * 2020-11-20 2021-12-10 中国科学院南海海洋研究所 一种通过添加纤维素酶来提高小疣刺参幼体成活率和附着率的方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803304A (en) * 1965-07-19 1974-04-09 Armour Pharma Orally administratable pancreatic enzymes and methods of using same
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
US3789117A (en) * 1971-07-19 1974-01-29 Freunt Ind Co Ltd Process for the preparation of enteric medicaments
AU501555B2 (en) * 1975-01-14 1979-06-21 Richter, Esdene Fluid operated device
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
AU516072B2 (en) * 1975-06-10 1981-05-14 Johnson & Johnson Enteric coated digestive enzyme composition
JPS536483A (en) * 1976-07-02 1978-01-20 Tanabe Seiyaku Co Ltd Composition having enzymatic activity and its preparation
IT1115596B (it) * 1978-03-13 1986-02-03 Bayer Italia Spa Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
US4230687A (en) * 1978-05-30 1980-10-28 Griffith Laboratories U.S.A., Inc. Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices
NL7908326A (nl) * 1978-11-20 1980-05-22 Tno Geimmobiliseerd enzym, werkwijzen ter bereiding daarvan en een werkwijze voor het uitvoeren van een enzymatische reactie.
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
US4447412A (en) * 1983-02-01 1984-05-08 Bilton Gerald L Enzyme-containing digestive aid compostions
GB8326633D0 (en) * 1983-08-04 1983-11-09 Unilever Plc Compositions
DE3445301A1 (de) * 1984-12-12 1986-06-12 Hoechst Ag, 6230 Frankfurt Pankreasenzympraeparate und verfahren zu deren herstellung
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
AU604052B2 (en) * 1986-08-28 1990-12-06 Enzacor Properties Limited Animal growth promotant
US5356625A (en) * 1986-08-28 1994-10-18 Enzacor Properties Limited Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals

Also Published As

Publication number Publication date
DK171626B1 (da) 1997-03-03
MY101342A (en) 1991-09-05
US5567423A (en) 1996-10-22
EP0319545A1 (en) 1989-06-14
JPH01503707A (ja) 1989-12-14
US5688502A (en) 1997-11-18
AU7872187A (en) 1988-03-24
ES2004989A6 (es) 1989-02-16
EP0319545B1 (en) 1992-03-18
CA1322159C (en) 1993-09-14
WO1988001512A1 (en) 1988-03-10
NZ221577A (en) 1990-05-28
JP2593501B2 (ja) 1997-03-26
DE3777658D1 (de) 1992-04-23
AU604052B2 (en) 1990-12-06
KR880701559A (ko) 1988-11-03
EP0319545A4 (en) 1989-06-13
CN87105846A (zh) 1988-05-04
KR940000065B1 (ko) 1994-01-05
DK236288D0 (da) 1988-04-28

Similar Documents

Publication Publication Date Title
DK236288A (da) Middel til fremme af dyrevaekst
DK236388D0 (da) Mikrogranulaert praeparat, der er anvendeligt til frigoerelse af biologisk aktive materialer i tarmregionerne hos dyr
ATE87469T1 (de) Verfahren zur herstellung einer formulierung mit verzoegerter freisetzung.
Shibata et al. Hydrolysis and absorption of pantothenate and its coenzymes in the rat small intestine
DE3586346D1 (de) Mikrobielle herstellung von propionsaeure in mischkultur.
FI882707A0 (fi) Foerfarande och preparat foer hoejning av proteinhalten i mjoelk.
ES8705229A1 (es) Procedimiento para la obtencion de una preparacion para aumentar la adhesion de bacterias al estomago e intestinos de seres humanos y animales
ES8706831A1 (es) Un procedimiento para preparar un aminoacido opticamente activo
PT81372B (pt) Processo para a preparacao de glicopeptidos e de composicoes anti-bacterianas que os contem
ATE94906T1 (de) Verfahren zur herstellung von l-alphaaminos|uren.
PT87071A (pt) Calciumlactat-glycerin-addukt verfahren zu seiner herstellung sowie seine verwendung
ATE200687T1 (de) Verfahren zur herstellung von kationenaustaucher- membranen mit unlöslichen metallsalzen
Pons et al. Permeability of chicken egg vitelline membrane to amino acids—binding of amino acids to egg proteins
JPS56109585A (en) Crosslinking of membrane containing microorganism
EA199800918A1 (ru) Происходящие от хозяина сигналы для индуцирования экспрессии гена изопреноида и их применение
SU1691866A1 (ru) Способ моделировани эмоционального стресса на животных
Sabatakou et al. Histochemical study of non-specific esterase activity in small and large intestine of young rabbit
JPS5581589A (en) Enzyme-containing film and method of making the same
JPS5799526A (en) Preparation of human adrenocorticotropic hormone
DE68924482D1 (de) Verfahren zur herstellung optisch aktiver 2-hydroxy-4-phenyl-3-butensäure.
Visentin A biochemical and morphological analysis of the renal and hepatic peroxisomes of the frog, Rana pipiens
Wiersema Enzyme studies of commercial shrimp
DE3887070D1 (de) Verfahren zur Herstellung von Brenztraubensäure durch Fermentation.
TH3980B (th) แกรนูลขนาดจิ๋วที่เตรียมขึ้นซึ่งมีประโยชน์ในการนำส่งสารแสดงฤทธิ์ทางชีวภาพไปยังบริเวณลำไส้ของสัตว์
JPS5551357A (en) Arbovirus agglutination method

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed